Kristen Wright, MSN, FNP, is a Family Nurse Practitioner; Catherine Coverston, PhD, RNC, is an Associate Professor and Associate Dean of Undergraduate Affairs; Mary Tiedeman, PhD, RN, is an Associate Professor; and Jo Ann Abegglen, MS, PNP, APRN, is an Associate Teaching Professor, Brigham Young University–Nursing, Provo, UT.
Formula Supplemented with Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA): A Critical Review of the Research
Article first published online: 6 APR 2006
Journal for Specialists in Pediatric Nursing
Volume 11, Issue 2, pages 100–112, April 2006
How to Cite
Wright, K., Coverston, C., Tiedeman, M. and Abegglen, J. A. (2006), Formula Supplemented with Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA): A Critical Review of the Research. Journal for Specialists in Pediatric Nursing, 11: 100–112. doi: 10.1111/j.1744-6155.2006.00048.x
- Issue published online: 6 APR 2006
- Article first published online: 6 APR 2006
- Fatty acids;
- human development;
- infant feeding;
- infant formula;
PURPOSE. To summarize results of randomized controlled trials (RCTs) evaluating growth, cognitive, neurological, and visual development of term infants supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA).
DESIGN AND METHODS. The Boyack and Lookinland Methodological Quality Index (MQI) was used to evaluate data from RCTs identified from multiple data bases.
RESULTS. Six of ten studies found the addition of DHA and ARA to have no significant effect on infant development.
PRACTICE IMPLICATIONS. More expensive formula with endogenous DHA and ARA is not necessary. Results from longer studies currently underway will be beneficial.